James G. Marken - 23 Aug 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP OPS & PROD DEV
Signature
/s/ James G. Marken, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
23 Aug 2023
Net transactions value
-$247,716
Form type
4
Filing time
25 Aug 2023, 16:17:55 UTC
Previous filing
12 Apr 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $152,212 +3,750 +2.8% $40.59 135,377 23 Aug 2023 Direct
transaction ANIP Common Stock Options Exercise $55,011 +1,667 +1.2% $33.00 137,044 23 Aug 2023 Direct
transaction ANIP Common Stock Sale $247,716 -3,932 -2.9% $63.00 133,112 23 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise $152,212 -3,750 -100% $40.59 0 23 Aug 2023 Common Stock 3,750 $40.59 Direct F1
transaction ANIP Stock Option (right to buy) Options Exercise $55,011 -1,667 -100% $33.00 0 23 Aug 2023 Common Stock 1,667 $33.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020.
F2 25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018.